Lymphoma Working Party (LWP)
          Study type:
    
Study number:
    84032218
      Type of treatment:
    CAR T
      Diseases:
    Non-Hodgkin’s Lymphoma (NHL)
      Short title:
    Holding & bridging therapy for MCL in CAR-T cell
      Primary objective:
    - Define standard practice for communication and patient referral among centers
- Describe holding strategies (therapy administered before leukapheresis)
- Describe bridging strategies (therapy administered after leukapheresis)
- Particular focus on targeted agents in the peri-CART setting:
- BTKi before and after CAR T-cell infusion
- Venetoclax before and after CAR T-cell infusion
      - Describe holding strategies (therapy administered before leukapheresis)
- Describe bridging strategies (therapy administered after leukapheresis)
- Particular focus on targeted agents in the peri-CART setting:
- BTKi before and after CAR T-cell infusion
- Venetoclax before and after CAR T-cell infusion
Key inclusion criteria:
    This study will focus on adult patients with relapsed or refractory mantle cell lymphoma (MCL) after two or more lines of systemic therapy including a Bruton’s tyrosine kinase (BTK) inhibitor; that is to say, patients who are candidates for brexu-cel therapy.
      Country:
    All EBMT member countries
      Principal investigator:
    Gloria Iacoboni, MD, PhD, Pere Barba, MD, PhD
      EBMT Study coordinator:
    Irma KHVEDELIDZE
      Study coordinator email:
    irma.khvedelidze@ebmt.org
      EBMT Study Unit:
    Paris Study Unit
      Reason for processing personal data:
    Not applicable to surveys
      Categories of personal data collected:
    Not applicable to surveys
      Recipients who may access the data:
    Not applicable to surveys
      3rd-party processors of Personal Data on behalf of EBMT/Service provider:
    Not applicable to surveys
      Privacy notices
Article 6 lawful basis for processing personal data:
    Not applicable to surveys
      Article 9 basis for processing special category data:
    Not applicable to surveys
      Data Protection Impact Assessments
Rights available to individuals:
    Access
          Data portability
          Rectification
          Objection
          Deletion
      Is a Data Protection Impact Assessment required?:
    Not applicable to surveys
      Retention Schedule (if possible):
    Not applicable to surveys